ArticleCell death discovery2026

Targeting androgen receptor as a novel radiosensitizing therapy to improve long-term survival and anti-tumor immunity in glioblastoma via TGF-β/Smad3 Axis reprogramming.

Jyoti B Kaushal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.